RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 668,174 Value ($000) $2,733 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 562,448 Value ($000) $2,745 Avg Close $5.25 Range $4.45 - $7.15

Q1 2025

Shares 652,644 Value ($000) $3,452 Avg Close $7.29 Range $5.19 - $12.36

Q2 2024

Shares 245,210 Value ($000) $1,839 Avg Close $8.72 Range $6.75 - $10.66

Q2 2023

Shares 800,320 Value ($000) $5,978 Avg Close $7.00 Range $4.54 - $10.45

Q1 2023

Shares 66,986 Value ($000) $447 Avg Close $7.93 Range $6.40 - $9.73

Q4 2022

Shares 151,339 Value ($000) $1,167 Avg Close $9.81 Range $7.04 - $13.29

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	668,174	$2,733	$4.95	$3.81 - $7.18
Q3 2025	562,448	$2,745	$5.25	$4.45 - $7.15
Q1 2025	652,644	$3,452	$7.29	$5.19 - $12.36
Q2 2024	245,210	$1,839	$8.72	$6.75 - $10.66
Q2 2023	800,320	$5,978	$7.00	$4.54 - $10.45
Q1 2023	66,986	$447	$7.93	$6.40 - $9.73
Q4 2022	151,339	$1,167	$9.81	$7.04 - $13.29